These findings suggest that serum levels of TGF-β1,GDF11,GDF15 all should be considered as a biomarker for MDD diagnosis, and their combination may serve as a promising multi-analyte diagnostic panel for MDD detection. This evidence concerns the gene GDF11 and major depressive disorder.